Midway through a M.D./Ph.D program at UCLA, Alice Zhang made a discovery that she felt could reverberate far beyond the halls of academia. So she shifted directions, leaving her Ph.D program to found Verge Genomics, a biomedical firm that aims to unite genetic research and artificial intelligence in service of drug discovery. She describes how AI can revolutionize the drug discovery process, and reframes risk-taking as a simple series of optimistic next steps.
Related
Ashley Flucas,
Flucas Ventures
The New Angel Investing [Entire Talk]
New users are flocking to angel investing platforms. What does this mean for investors and startups?
Ashley Flucas,
Flucas Ventures
The New Angel Investing [Entire Talk]
New users are flocking to angel investing platforms. What does this mean for investors and startups?
Jon Zieger,
Responsible Innovation Labs
What is Responsible Innovation? [Entire Talk]
Ambitious technology companies will shape the 21st century. Could new frameworks help them shape it in a positive direction?
Jon Zieger,
Responsible Innovation Labs
What is Responsible Innovation? [Entire Talk]
Ambitious technology companies will shape the 21st century. Could new frameworks help them shape it in a positive direction?
Luke Sykora,
Stanford University
How to Rethink Competition
Pay attention to competitors, sure. But to catalyze innovation, pay attention to more than the usual suspects.